180 related articles for article (PubMed ID: 33827655)
1. FDG-PET/CT in intensive care patients with bloodstream infection.
Pijl JP; Londema M; Kwee TC; Nijsten MWN; Slart RHJA; Dierckx RAJO; van der Voort PHJ; Glaudemans AWJM; Pillay J
Crit Care; 2021 Apr; 25(1):133. PubMed ID: 33827655
[TBL] [Abstract][Full Text] [Related]
2. FDG-PET/CT for Detecting an Infection Focus in Patients With Bloodstream Infection: Factors Affecting Diagnostic Yield.
Pijl JP; Glaudemans AWJM; Slart RHJA; Yakar D; Wouthuyzen-Bakker M; Kwee TC
Clin Nucl Med; 2019 Feb; 44(2):99-106. PubMed ID: 30516689
[TBL] [Abstract][Full Text] [Related]
3. Clinical implications of increased uptake in bone marrow and spleen on FDG-PET in patients with bacteremia.
Pijl JP; Kwee TC; Slart RHJA; Yakar D; Wouthuyzen-Bakker M; Glaudemans AWJM
Eur J Nucl Med Mol Imaging; 2021 May; 48(5):1467-1477. PubMed ID: 33106925
[TBL] [Abstract][Full Text] [Related]
4.
Liu C; Gong C; Liu S; Zhang Y; Zhang Y; Xu X; Yuan H; Wang B; Yang Z
Oncologist; 2019 Dec; 24(12):e1277-e1285. PubMed ID: 31337657
[TBL] [Abstract][Full Text] [Related]
5. Importance of Blood Glucose Management Before
Pijl JP; Glaudemans AWJM; Gheysens O; Slart RHJA; Kwee TC
J Nucl Med; 2023 Aug; 64(8):1287-1294. PubMed ID: 37414447
[TBL] [Abstract][Full Text] [Related]
6. [
Sollini M; Trenti N; Malagoli E; Catalano M; Di Mento L; Kirienko A; Berlusconi M; Chiti A; Antunovic L
Eur J Nucl Med Mol Imaging; 2019 Jul; 46(8):1605-1615. PubMed ID: 31044264
[TBL] [Abstract][Full Text] [Related]
7. Role of FDG-PET/CT in children with fever of unknown origin.
Pijl JP; Kwee TC; Legger GE; Peters HJH; Armbrust W; Schölvinck EH; Glaudemans AWJM
Eur J Nucl Med Mol Imaging; 2020 Jun; 47(6):1596-1604. PubMed ID: 32030452
[TBL] [Abstract][Full Text] [Related]
8. More advantages in detecting bone and soft tissue metastases from prostate cancer using
Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
[TBL] [Abstract][Full Text] [Related]
9. C-reactive protein levels can predict positive
Tsai HY; Lee MH; Wan CH; Yang LY; Yen TC; Tseng JR
J Microbiol Immunol Infect; 2018 Dec; 51(6):839-846. PubMed ID: 30190232
[TBL] [Abstract][Full Text] [Related]
10. The value of
Schönau V; Vogel K; Englbrecht M; Wacker J; Schmidt D; Manger B; Kuwert T; Schett G
Ann Rheum Dis; 2018 Jan; 77(1):70-77. PubMed ID: 28928271
[TBL] [Abstract][Full Text] [Related]
11. Impact of Fluorine-18 2-Fluoro-2-Deoxy-D-Glucose Uptake on Preoperative Positron Emission Tomography/Computed Tomography in the Lymph Nodes of Patients with Primary Colorectal Cancer.
Sasaki K; Kawasaki H; Sato M; Koyama K; Yoshimi F; Nagai H
Dig Surg; 2017; 34(1):60-67. PubMed ID: 27454870
[TBL] [Abstract][Full Text] [Related]
12. Clinical impact and diagnostic accuracy of 2-[
Motara H; Olusoga T; Russell G; Jamieson S; Ahmed S; Brindle N; Pillai A; Scarsbrook AF; Patel CN; Chowdhury FU
Clin Radiol; 2017 Jan; 72(1):63-73. PubMed ID: 27637430
[TBL] [Abstract][Full Text] [Related]
13. Diagnostic performance of
Chaput A; Robin P; Podeur F; Ollivier M; Keromnes N; Tissot V; Nonent M; Salaün PY; Rousset J; Abgral R
Laryngoscope; 2018 Feb; 128(2):378-385. PubMed ID: 28600822
[TBL] [Abstract][Full Text] [Related]
14. Prognostic implication of fluorine-18 fluorodeoxyglucose positron emission tomography/computed tomography in patients with recurrent papillary thyroid cancer.
Kang JH; Jung DW; Pak KJ; Kim IJ; Kim HJ; Cho JK; Shin SC; Wang SG; Lee BJ
Head Neck; 2018 Jan; 40(1):94-102. PubMed ID: 29130586
[TBL] [Abstract][Full Text] [Related]
15. Evidence of Clinical Impact Supports a New Petition for Medicare Coverage of 2-[18F]Fluoro-2-Deoxy-D-Glucose Positron Emission Tomography/Computed Tomography in the Evaluation of Staphylococcus aureus Bacteremia: A Focused Literature Review and Call to Action.
Thottacherry E; Cortés-Penfield NW
Clin Infect Dis; 2022 Oct; 75(8):1457-1461. PubMed ID: 35535794
[TBL] [Abstract][Full Text] [Related]
16. Practice of
van Leer B; van Rijsewijk ND; Nijsten MWN; Slart RHJA; Pillay J; Glaudemans AWJM
Semin Nucl Med; 2023 Nov; 53(6):809-819. PubMed ID: 37258380
[No Abstract] [Full Text] [Related]
17. Diagnostic Value of
Voskuilen CS; Schweitzer D; Jensen JB; Nielsen AM; Joniau S; Muilwijk T; Necchi A; Azizi M; Spiess PE; Briganti A; Bandini M; Goffin K; Bouchelouche K; van Werkhoven E; Shariat SF; Xylinas E; Azawi NH; Ku JH; Foerster B; van Rhijn BWG; Vegt E; Hendricksen K
Eur Urol Oncol; 2020 Feb; 3(1):73-79. PubMed ID: 31591037
[TBL] [Abstract][Full Text] [Related]
18. Diagnostic value of positron emission tomography combined with computed tomography for evaluating patients with septic shock of unknown origin.
Kluge S; Braune S; Nierhaus A; Wichmann D; Derlin T; Mester J; Klutmann S
J Crit Care; 2012 Jun; 27(3):316.e1-7. PubMed ID: 22176803
[TBL] [Abstract][Full Text] [Related]
19. FDG-PET/CT and MRI for Evaluation of Pathologic Response to Neoadjuvant Chemotherapy in Patients With Breast Cancer: A Meta-Analysis of Diagnostic Accuracy Studies.
Sheikhbahaei S; Trahan TJ; Xiao J; Taghipour M; Mena E; Connolly RM; Subramaniam RM
Oncologist; 2016 Aug; 21(8):931-9. PubMed ID: 27401897
[TBL] [Abstract][Full Text] [Related]
20. Using positron emission tomography (PET) response criteria in solid tumours (PERCIST) 1.0 for evaluation of 2'-deoxy-2'-[18F] fluoro-D-glucose-PET/CT scans to predict survival early during treatment of locally advanced non-small cell lung cancer (NSCLC).
Fledelius J; Khalil AA; Hjorthaug K; Frøkiaer J
J Med Imaging Radiat Oncol; 2016 Apr; 60(2):231-8. PubMed ID: 26678718
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
